Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
about
Poly Cystic Ovarian Syndrome: An Updated OverviewComplications and challenges associated with polycystic ovary syndrome: current perspectivesPregnancy complications in women with polycystic ovary syndromeNonhuman primate models of polycystic ovary syndromeMetabolic disturbance in PCOS: clinical and molecular effects on skeletal muscle tissueObesity and PCOS: implications for diagnosis and treatmentInflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunctionPolycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age WomenDyslipidemia in women with polycystic ovary syndromeHealth and fertility in World Health Organization group 2 anovulatory womenRelationship between Advanced Glycation End Products and Steroidogenesis in PCOSDoes endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome?Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.CLINICAL PRACTICE. Polycystic Ovary Syndrome.A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.Visceral adiposity index: an indicator of adipose tissue dysfunction.Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.Hyperandrogenism induces a proinflammatory TNFα response to glucose ingestion in a receptor-dependent fashionInsulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guidelineDevelopmental programming: impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheepGlucose and lipopolysaccharide regulate proatherogenic cytokine release from mononuclear cells in polycystic ovary syndrome.Association between follicular fluid leptin and serum insulin levels in nonoverweight women with polycystic ovary syndrome.Increased androgen, anti-Müllerian hormone, and sporadic anovulation in healthy, eumenorrheic women: a mild PCOS-like phenotype?Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transitionHeart rate variability in normal-weight patients with polycystic ovary syndromeNonalcoholic fatty liver disease and polycystic ovary syndrome.Brachial-to-ankle pulse wave velocity as an independent prognostic factor for ovulatory response to clomiphene citrate in women with polycystic ovary syndrome.Circulating vascular progenitor cells and central arterial stiffness in polycystic ovary syndrome.Children's Hospital Association consensus statements for comorbidities of childhood obesityThe association between androgen receptor gene CAG polymorphism and polycystic ovary syndrome: a case-control study and meta-analysis.Abnormal infant islet morphology precedes insulin resistance in PCOS-like monkeysAfamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome.Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype.Metabolic abnormalities in adolescents with polycystic ovary syndrome in south ChinaEffects of thiazolidinediones on polycystic ovary syndrome: a meta-analysis of randomized placebo-controlled trials.Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndromeNitric oxide-mediated cutaneous microvascular function is impaired in polycystic ovary sydrome but can be improved by exercise training.Evidence of mononuclear cell preactivation in the fasting state in polycystic ovary syndromeReduced estradiol-induced vasodilation and poly-(ADP-ribose) polymerase (PARP) activity in the aortas of rats with experimental polycystic ovary syndrome (PCOS).
P2860
Q26752564-9C1B8685-AF31-4B57-8EF0-A24825A30C3BQ26799566-6CA00C28-818C-474B-A7F3-58213A7EB61EQ26822402-205EB921-2E4A-4402-A750-0EA9B65CD003Q26829385-C4CEEBAB-DC62-4E13-8934-8FFD964BD426Q26830631-2D01B6ED-1419-41F6-95EB-62500000A8BFQ27000954-FCE59F93-ED37-42A0-B95A-EFF27BC7EFA0Q27011541-1753115A-5BED-455B-A582-C1AC8DF8C7A4Q27021307-C799C95F-B6F4-4CBA-BE34-29F6C32F4E49Q27025695-DC3FA80B-DE26-4AAD-96CD-379482561C23Q27026624-DB954358-D699-46B7-A714-C7A50892445FQ28077960-B16DA615-AF61-49B9-92E8-CE174525FDF2Q28079172-D4D3B76F-00AB-48E2-9911-05445B21945CQ28390200-02F71E86-DCFA-4A45-A429-FA010E0851C9Q29248890-C19EC5F1-9778-4F5C-8FB5-08790E904226Q30356743-533F885C-DC2F-4DC9-A142-9BA504A877AEQ33563343-0A6E72AA-291B-4E2E-A905-142BA3605381Q33568979-A0BFF216-0716-4F77-ADDA-C965C845C92BQ33569067-D9B7A8BB-C994-4787-88EB-7902115977BFQ33569169-C307E147-5BC4-4818-A955-0B2B39CD11A1Q33587845-22FA54AC-AFAB-4344-AC66-F171A4D484AFQ33593356-52BDED62-D2D9-4E3A-A399-4308F3185FE6Q33610805-384C4478-D3A0-4098-803C-1A862936BB34Q33634846-AB4A71B3-F6F6-439B-A46E-D8E70F9736B1Q33682407-289D468B-0008-4D0F-8FF1-4CEC7D3C4156Q33682425-EC3E0E18-14F0-426E-9333-5B9E512F2BA0Q33792016-C526293B-89A5-4B13-9ADB-7DF271F54743Q33886930-1745E737-6860-4C4C-AAB9-3FBC498F9408Q33895746-2BC1E52D-D932-44B3-9EAE-B3B7B296C615Q33927310-ABAF2D80-991D-4617-8D49-381E90C37EB4Q33997334-57A5E14C-5E23-4C24-B031-A40FD532FF02Q34145721-D124EDBC-7A7C-49E5-8D5F-979B0ACD78A1Q34159978-2FBB80B5-1247-45B1-BE0D-348133E6F64FQ34227276-F195321B-A981-4A69-AE39-AEA2A7ED9D2BQ34331658-F5289180-3420-4422-83FD-EAFDBD67AD72Q34366951-0E3CDF9D-1638-437F-8A57-24274A665F42Q34397685-00313882-21EA-4F5F-8D95-40E1F51AB741Q34536081-DA526EC0-F0C0-4FC7-86E0-5F408150985CQ34547852-4C80C84A-4FB2-4683-9A01-63A146E37A11Q34620242-7D12DC74-5362-4B85-A44E-BF5BF738666BQ34650147-D8C8C419-E8EB-400A-A471-3E7544AC7A71
P2860
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Assessment of cardiovascular r ...... ry Syndrome (AE-PCOS) Society.
@en
Assessment of cardiovascular r ...... and Polycystic Ovary Syndrome
@nl
type
label
Assessment of cardiovascular r ...... ry Syndrome (AE-PCOS) Society.
@en
Assessment of cardiovascular r ...... and Polycystic Ovary Syndrome
@nl
prefLabel
Assessment of cardiovascular r ...... ry Syndrome (AE-PCOS) Society.
@en
Assessment of cardiovascular r ...... and Polycystic Ovary Syndrome
@nl
P2093
P50
P356
P1476
Assessment of cardiovascular r ...... ry Syndrome (AE-PCOS) Society.
@en
P2093
Anuja Dokras
Daniel A Dumesic
Enrico Carmina
Hector F Escobar-Morreale
Robert A Wild
Rogerio Lobo
Walter Futterweit
P304
P356
10.1210/JC.2009-2724
P407
P577
2010-04-07T00:00:00Z